Information  X 
Enter a valid email address

Standard Life Priv (SLPE)

  Print      Mail a friend       Annual reports

Tuesday 06 November, 2018

Standard Life Priv

Director/PDMR Shareholding

RNS Number : 5323G
Standard Life Private Eqty Trst PLC
06 November 2018
 

Standard Life Private Equity Trust plc ("the Company")

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

Roger Pim

2

 

Reason for the notification

 

a)

 

Position/status

 

PDMR

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Standard Life Private Equity Trust plc

b)

 

LEI

 

2138004MK7VPTZ99EV13

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of 0.2p each

 

 

SLPE

 

b)

 

Nature of the transaction

 

Purchase under Dividend Re-Investment Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

341.00 pence

694

341.00 pence

68 (held in Roger Pim's ISA account)

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

762 Ordinary Shares of 0.2p each

 

341.00p   

e)

 

Date of the transaction

 

26 October 2018

f)

 

Place of the transaction

 

London

g)

Name of contact and telephone number for queries

Mandy Kelly, Maven Capital Partners UK LLP

Company Secretary (Tel: 0141 206 0124)

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHLLFFELSLRIIT

a d v e r t i s e m e n t